![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1358, 2002-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drotrecogin-alfa warranted to tackle severe sepsis burden in Europe
Inpharma, Vol. 1, Iss. 1368, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drotrecogin-alfa warranted to tackle severe sepsis burden in Europe
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 391, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drotrecogin alfa improves organ function in severe sepsis
Inpharma, Vol. 1, Iss. 1389, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Should patients with severe sepsis receive drotrecogin alfa?
Inpharma, Vol. 1, Iss. 1508, 2005-01 ,pp. :